Healthy Skepticism Library item: 4679
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Newman TB.
Possibly disappointing results of treatment with gemfibrozil.
N Engl J Med 1993 Jan 14; 328:(2):139-40
Abstract:
Parke-Davis did not try to hide any information about the usefulness of gemfibrozil (Lopid). When recent changes to the Lopid package insert were made, Parke-Davis sent out “Dear Doctor†letters to 170000 physicians and 60000 pharmacists. The letter was also published in 12 leading medical journals.
Keywords:
*letter to the editor/United States/Parke-Davis/Lopid/ reporting of results/industry perspective/INFLUENCE OF PROMOTION: PUBLICATION
Notes:
Reply to: Thomas B. Newman, New England Journal of Medicine 1993;328:139-140.
Conflict of interest: Drs. Canter and Perlow work for Parke-Davis.